BRCA MASTR v2.1

  • Catalog: MASTR Assays
The new BRCA MASTR v2.1 amplifies all coding regions of BRCA 1&2 genes in only 5 multiplex PCR reactions.

Product characteristics:
  • > 95 % on-target specificity
  • 93 amplicons for complete coding exon coverage of the BRCA1&2 genes 
  • Amplicon normalization is achieved by careful multiplex optimization and fixed mixing scheme
  • Robust standard PCR protocol  
  • Max. 50 ng input DNA needed per multiplex reaction 
  • Increased troughput by sequencing more samples in parallel
  • Suited to automated workflows
  • Cost-effective target amplification, minimizing hands-on-time
  • Amplicon parameters available for SeqNext users 

The assay is compatible with Titanium chemistry for amplicon sequencing on the GS-FLX and GS Junior from 454/Roche. An adapted protocol for "short read sequencing technologies" is also available, you can find these protocols in the download section below.  

We recommend the use of our 454 MID kits to all customers using 454 sequencing technology. These optimized kits contain all reagents for MID incorporation and Genescan analysis (optional). 
We also offer assays for the analysis of the coding homopolymer stretches in BRCA1&2:
Please check the "MASTR related products" group for more details.

“The information obtained from amplicons generated using this product may not be used in procedures that are protected by valid patent claims owned and/or controlled by a third party, unless prior written approval of such party has been obtained”.